- Generic name
- Dexamethasone
- Strength
- .5 mg
- Dosage form
- Tablet
- Manufactured by
- Square Pharmaceuticals PLC.
Dexonex Tablet
About Dexonex .5 mg Tablet
Dexonex is a tablet made by Square Pharmaceuticals PLC. It contains dexamethasone, a corticosteroid medicine. Each tablet carries the strength .5 mg.
There are 47 brands of Dexamethasone listed in Bangladesh. The lowest listed price is B-Dexa .5 mg Tablet at ৳ 0.5 per unit.
What is Dexonex .5 mg Tablet?
Dexonex is a brand of dexamethasone tablets from Square Pharmaceuticals PLC. Dexamethasone belongs to a group of medicines called glucocorticoids, which are steroid medicines. It works by reducing inflammation and by suppressing the normal immune response. It is used in allergic states and in some collagen diseases such as lupus erythematosus and rheumatoid arthritis. Dexonex tablets are supplied in a .5 mg strength. Because steroid medicines are powerful, they are used under medical supervision, and the doctor decides whether they suit a particular person.
Uses of Dexonex
Dexonex is used for allergic states that have not responded well enough to usual treatment, including asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, allergic rhinitis and serum sickness. It is also used in some collagen diseases, such as lupus erythematosus and rheumatoid arthritis. Only a doctor can decide whether this medicine is appropriate for a person's condition.
How to use Dexonex
Dexonex is a tablet that is swallowed. The doctor decides the dose and how long it is taken, based on the condition and the person's response. If there is no favourable response within a couple of days, the doctor may reconsider continuing it. In long-term use the smallest dose that gives adequate relief is preferred, and any reduction is made gradually. Do not change the dose without asking the doctor.
Side effects of Dexonex
Side effects are mainly linked with prolonged use of steroid medicines. These can include hormonal and metabolic changes, fluid and salt retention with raised blood pressure, potassium loss, muscle and bone effects, and stomach and intestinal problems such as ulcers. Not everyone gets them. If you notice any unusual symptoms while taking Dexonex, tell your doctor or pharmacist, who can advise on what to do.
Safety and precautions
Dexonex should be used with caution in people with heart failure, high blood pressure or kidney problems, and in those with active or hidden stomach ulcers or certain bowel conditions. It is not for people with stomach or duodenal ulcers, fungal infections, certain viral infections, glaucoma, or allergy to corticosteroids. In pregnancy it is used only if the benefit justifies the risk, and mothers on high doses should not breast-feed. Tell your doctor about other medicines you take, including diuretics, heart medicines, antidiabetics, pain relievers and blood thinners, before starting.
Frequently asked questions
What is Dexonex used for, and what kind of medicine is it?
Dexonex is a tablet containing dexamethasone, a glucocorticoid or steroid medicine. It reduces inflammation and suppresses the immune response. It is used in allergic conditions such as asthma, dermatitis and allergic rhinitis, and in some collagen diseases. Your doctor decides if it is right for you.
How should Dexonex be taken?
Swallow the tablet as your doctor tells you. The doctor decides the dose and the course, based on your condition and response. Do not adjust the dose yourself, and if you are on long-term treatment, follow the doctor's advice on gradual reduction rather than stopping suddenly.
What does the generic name dexamethasone mean?
Dexamethasone is the generic name of the active substance in Dexonex. It is a synthetic glucocorticoid, a type of steroid medicine that lowers inflammation and suppresses the immune response. The generic name helps you recognise the same medicine in other brands too.
Who should ask a doctor before taking Dexonex?
Ask your doctor first if you have heart, blood pressure or kidney problems, stomach ulcers or bowel disease, glaucoma, diabetes, or an infection, or if you are pregnant or breast-feeding. Also tell the doctor about all other medicines you take, since some can interact with steroids.
Also available as
Indications
Collagen disease ... Read moreAllergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis and serum sickness.
Collagen disease: Like lupus erythematosus, rheumatoid arthritis etc.
Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus and severe erythema multiforme (Stevens-Johnson syndrome).
Endocrine disorders: Primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with cancer and nonsuppurative thyroiditis.
Gastrointestinal diseases: Regional enteritis and ulcerative colitis.
Hematologic disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults and selected cases of secondary thrombocytopenia.
Neoplastic diseases: Leukemias and lymphomas.
Nervous system: Acute exacerbations of multiple sclerosis, cerebral edema associated with primary or metastatic brain tumor, craniotomy or head injury.
Ophthalmic diseases: Temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.
Renal diseases: To induce a diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus.
Respiratory diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis.
Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus.
Miscellaneous: Diagnostic testing of adrenocortical hyperfunction, trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy.
Pharmacology
Dosage & Administration
For tablet:
- In adult patients, daily oral dosages vary from 1 mg to 10 mg and in children from 0.03-0.20 mg/kg body weight,according to the individual response.
- In some patients higher dosages may be temporarily required,to control the disease. As soon as circumstances permit,dosage should be decreased.
- For a short dexamethasone suppression test 1 mg dexamethasone is given at 11 p.m. and plasmacortisol measured the next morning.
- Patients who do not show a decrease in cortisol can be exposed to a longer test: 0.5 mg dexamethasone is given at 6-hour intervals
- for 48 hours followed by 2 mg every 6 hours for a further 48 hours. 24-hour urine collections are made before, during and at the end of the test for the determination of 17 alpha-hydroxycorticoids.
- Dexamethasone can be given by intravenous (IV), intramuscular (IM) or local injection. Dexamethasone injections can also be diluted with an infusion fluid or be injected directly into the infusion line.
- Intravenous injections of massive doses should be given slowly, over a period of several minutes.
- Intramuscular administration should be given by deep intramuscular injection,to prevent atrophy of the subcutaneous adipose tissues.
- Intra-articular injections should be given under strictly aseptic conditions as glucocorticoids decrease the resistance to infection. When diluted with these infusion fluids, Dexamethasone will keep its potency for at least 24 hours (at room temperature and in daylight conditions). As infusion fluids, Sodium chloride 0.9%, Anhydrous glucose 5%, Invert sugar 10%, Sorbitol 5%, Ringer's solution, Hartman's solution (Ringer-lactate) etc.can be used.
- The dosage of Dexamethasone depends on the severity of the condition and the response of the patient.
- For systemic therapy in adults, daily doses of 0.05-0.20 mg/kg body weight are usually sufficient. For emergencies (e.g. anaphylaxis, acute severe asthma, cerebral edema) substantially higher doses are required. An initial dose of 10-20 mg IV is followed by 6 mg IV or IM every 6 hours,until a satisfactory result has been obtained. Thereafter the dosage has to be tapered off gradually.
- Intra-articularly: 2-4 mg in large and 0.8-1 mg in small joints
- Intrabursally: 2-4 mg;in tendon sheaths:0.4-1 mg
- The frequency of these injections may vary from every 3-5 days to every 2-3 weeks
Interaction
- Diuretics and/or cardiac glycosides, since potassium loss may be enhanced.This is a particular risk in patients using cardiac glycosides; since hypokalaemia increases the toxicity of these drugs.
- Antidiabetics, since glucocorticoids may impair glucose tolerance, thereby increasing the need for antidiabetic drugs.
- Non-steroidal anti-inflammatory drugs, since the incidence and/or severity of gastro-intestinal ulceration may increase.
- Oral anti-coagulants since glucocorticoids may alter the need for these drugs.
- Glucocorticoids may be less effective when used concomitantly with liver enzyme inducing drugs,such as rifampicin, ephedrine, barbiturates, phenytoin and primidone.
- If patients undergoing long-term therapy with glucocorticoids are concomitantly given salicylates, any reduction in glucocorticoid dosage should be made with caution, since salicylate intoxication has been reported in such cases.
- Antacids;especially those containing magnesium trisilicate,have been reported to impair the gastro-intestinal absorption of glucocorticoids. Therefore, doses of one agent should be spaced as far as possible from the other.
Contraindications
- Gastric and duodenal ulcers.
- Systemic and ophthalmic fungal infections.
- Viral infections, e.g. varicella and herpes genitalis infections. Viral infections of the eye.
- Glaucoma.
- Hypersensitivity to corticosteroids
Side Effects
Endocrine and metabolic disturbances: Cushing-like syndrome, hirsutism, menstrual irregularities, premature epiphyseal closure, secondary adrenocortical and pituitary unresponsiveness, decreased glucose tolerance, negative nitrogen and calcium balance.
Fluid and electrolyte disturbances: Sodium and fluid retention, hypertension, potassium loss, hypokalaemic alkalosis.
Musculo-skeletal effects: Myopathy, abdominal distension, osteoporosis, aseptic necrosis of femoral and humeral heads.
Gastro-intestinal effects: Gastric and duodenal ulceration, perforation and haemorrhage.
Dermatological effects: Impaired wound healing, skin atrophy, striae, petechiae and ecchymoses, bruising, facial erythema, increased sweating, acne.
Central Nervous System effects: Psychic disturbances ranging from euphoria to frank psychotic manifestations,convulsions,in children pseudotumor cerebri (benign intracranial hypertension) with vomiting and papilloedema.
Ophthalmic effects: Glaucoma, increased intraocular pressure, posterior subcapsular cataracts.
Immunosuppressive effects: Increased susceptibility to infections, decreased responsiveness to vaccination and skin tests.
Pregnancy & Lactation
Precautions & Warnings
Cardio-renal: These agents should be used with caution in patients with congestive heart failure,hypertension, or renal insufficiency.
Endocrine: Drug-induced secondary adrenocortical insufficiency may be minimized by gradual reduction of dosage.
Gastrointestinal: Steroids should be used with caution in active or latent peptic ulcers, diverticulitis, intestinal anastomoses, and nonspecific ulcerative colitis, since they may increase the risk of a perforation.
Musculoskeletal: Special consideration should be given to patients at increased risk of osteoporosis (e.g.,postmenopausal women) before initiating corticosteroid therapy.
Neuro-psychiatric: An acute myopathy has been observed with the use of high doses of corticosteroids, most often occurring in patients with myasthenia gravis or in patients receiving concomitant therapy with neuromuscular blocking drugs (e.g., pancuronium). Psychic derangements may appear ranging from euphoria, insomnia, mood swings, personality changes, and severe depression, to frank psychotic manifestations.
Overdose Effects
Storage Conditions
Injection: Store below 30° C, protected from light.Do not freeze. Keep medicines out of the reach of children
Alternative brands of Dexamethasone
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.